Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ADVM | Adverum Biotechnologies, Inc. | Director | $140K | +$135K | +2999% | Jun 17, 2024 |
ALGS | Aligos Therapeutics, Inc. | Director | $139K | Jun 27, 2024 | ||
DICE | DICE Therapeutics, Inc. | Director | Aug 9, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|